Chem. J. Chinese Universities ›› 2025, Vol. 46 ›› Issue (1): 20230525.doi: 10.7503/cjcu20230525

• Review • Previous Articles     Next Articles

Research Progress in Nanomaterial-induced Cuproptosis in Tumor Cells

HE Kuo1,2, DING Binbin1(), MA Ping’an1,2(), LIN Jun1,2()   

  1. 1.State Key Laboratory of Rare Earth Resource Utilization,Changchun Institute of Applied Chemistry,Chinese Academy of Sciences,Changchun 130022,China
    2.School of Applied Chemistry and Engineering,University of Science and Technology of China,Hefei 230026,China
  • Received:2023-12-26 Online:2025-01-10 Published:2024-02-21
  • Contact: DING Binbin, MA Ping’an, LIN Jun E-mail:bbding@ciac.ac.cn;mapa675@ciac.ac.cn;jlin@ciac.ac.cn
  • Supported by:
    the Science and Technology Development Planning Project of Jilin Province, China(20220101070JC);the National Natural Science Foundation of China(52102354)

Abstract:

Nanomaterials are considered as promising cancer treatment materials by selectively inducing programmed cell death(PCD) of tumor cells. Cuproptosis is a newly discovered PCD pattern caused by intracellular copper ion overload, characterized by the aggregation of acylated mitochondrial enzymes and the loss of Fe-S proteins. Various nanomaterials have been developed to induce cuproptosis in tumor cells as a treatment for cancer. Numerous studies have demonstrated that cuproptosis achieves better anti-tumor effects when combined with other tumor therapeutic modalities, showing a great potential. This paper introduces the mechanisms and characteristics of cellular cuproptosis, outlines the strategies and mechanisms of nanomaterial-induced cuproptosis in tumor cells, focuses on classifying and outlining the recent research progress of nanomaterial-induced cuproptosis combination therapy, and looks forward to the future prospects of this emerging therapeutic modality.

Key words: Cuproptosis, Programmed cell death, Nanomaterial, Tumor treatment

CLC Number: 

TrendMD: